An Algorithm for Tuberculosis Screening and Diagnosis in People with HIV

Efficient, economical screening for active tuberculosis in resource-poor environments is a challenge. Screening is particularly important when there is coinfection with human immunodeficiency virus (HIV) and therefore concomitant consideration of initiation of antiretroviral therapy and the risk of...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 362; no. 8; pp. 707 - 716
Main Authors Cain, Kevin P, McCarthy, Kimberly D, Heilig, Charles M, Monkongdee, Patama, Tasaneeyapan, Theerawit, Kanara, Nong, Kimerling, Michael E, Chheng, Phalkun, Thai, Sopheak, Thai, Le Hung, Sar, Borann, Phanuphak, Praphan, Phanuphak, Nittaya, Teeratakulpisarn, Nipat, Dung, Nguyen Huy, Quy, Hoang Thi, Varma, Jay K
Format Journal Article
LanguageEnglish
Published Waltham, MA Massachusetts Medical Society 25.02.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Efficient, economical screening for active tuberculosis in resource-poor environments is a challenge. Screening is particularly important when there is coinfection with human immunodeficiency virus (HIV) and therefore concomitant consideration of initiation of antiretroviral therapy and the risk of the immune reconstitution syndrome. In this study of 1748 patients in Cambodia, Thailand, and Vietnam who were infected with HIV, an assessment for the presence of one of three symptoms — cough, fever, or night sweats — for more than 21 days over the preceding 4 weeks was found to have 93% sensitivity and 36% specificity for the detection of active tuberculosis infection. In this study of patients in Cambodia, Thailand, and Vietnam who were infected with HIV, an assessment for the presence of one of three symptoms — cough, fever, or night sweats — for more than 21 days over the preceding 4 weeks was found to have 93% sensitivity and 36% specificity for the detection of active tuberculosis infection. Tuberculosis is a leading cause of death among adults who are infected with the human immunodeficiency virus (HIV). 1 In some countries, death occurs in up to 50% of these patients during treatment for tuberculosis, usually within 2 months after tuberculosis has been diagnosed. 2 – 6 Delayed diagnosis of tuberculosis is probably an important contributor to high mortality. 7 Antiretroviral therapy can substantially reduce the risk of death, 2 , 4 but initiating this therapy in a patient with untreated tuberculosis can lead to the immune-reconstitution inflammatory syndrome. 8 – 13 To reduce the risk of tuberculosis, the World Health Organization (WHO) recommends the use of isoniazid . . .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa0907488